Related Experiment Video
Updated: Jul 4, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
[Recommendations of antifungal treatment in patients with low grade immunosuppression]
J Barberán1, J Mensa, C Fariñas
1Sociedad Española de Medicina Interna (SEMI), Madrid. josebarberan@telefonica.net
Abstract:
Because of the relevance that the systemic mycoses has acquired in non-highly immunocompromised patients, the treatment difficulties they have due to the increase of the non-albicans Candida species and the need to have a better and more rational use of the new antifungal agents (voriconazole, posaconazole, caspofungin, anidulafungin and micafungin), an experts' panel on infectious diseases in representation of the Spanish Society of Chemotherapy, Spanish Society of Internal Medicine, and Spanish Society of Pneumology and Thoracic Surgery has met in order to make a few recommendations based on the scientific evidence in an effort to improve their efficiency.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Candidiasis
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Fungal Phylum Microsporidia
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
